• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

ユビキチン化によるアクアポリン2の輸送制御機構の研究

Research Project

Project/Area Number 21F20800
Research Category

Grant-in-Aid for JSPS Fellows

Allocation TypeSingle-year Grants
Section外国
Review Section Basic Section 43020:Structural biochemistry-related
Research InstitutionTokyo Medical and Dental University

Principal Investigator

藤吉 好則  東京医科歯科大学, 高等研究院, 特別栄誉教授 (80142298)

Co-Investigator(Kenkyū-buntansha) PALUDA ANDREJ  東京医科歯科大学, 高等研究院, 外国人特別研究員
Project Period (FY) 2021-07-28 – 2023-03-31
Project Status Completed (Fiscal Year 2022)
Budget Amount *help
¥2,300,000 (Direct Cost: ¥2,300,000)
Fiscal Year 2022: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 2021: ¥1,200,000 (Direct Cost: ¥1,200,000)
KeywordsAquaporin-2 / Ubiquitin / E3 ligase / FSEC / CryoEM / AQP-2
Outline of Research at the Start

ヒトの身体で最も多い分子は水であり、それゆえ、水含量は身体の恒常性維持には重要である。その水含量は、アクアポリン-2(AQP2)と呼ばれる水チャネルが腎臓の尿細管表面に存在する量によって、ダイナミックに制御されている。AQP2はユビキチン化されることなどにより細胞内に取り込まれたり、分解を受けたりすることが知られているが、そのAQP2を修飾するE3と呼ばれる合成酵素とAQP2との相互作用を構造学的に研究することで、尿細管の細胞表面におけるAQP2の量を制御する薬剤の設計にも役立つ構造情報を取得する。

Outline of Annual Research Achievements

E3 ligases CHIP and NEDD4 family members have been cloned, expressed and purified, however in the later stages of screening the interest focused on NEDD4L protein.
Co-elution of AQP2 was examined with several E3 ligases including CHIP, NEDD4, NEDD4L, ITCH, Arih2, however without any binding observed.
This suggested involvement of scaffold proteins including 14-3-3 and HSP70 or phosphorylation of NEDD4L. These additional proteins and phospho-variants of NEDD4L were prepared, however as before no binding was observed.
Furthermore, fusion constructs of N-terminal (intra-cellular) region of NDFIP1/2, reported to bind NEDD4L, and the AQP2 were prepared. So far, NDFIP2-AQP2 fusion was successfully solubilised and purified with initial binding experiments following soon.
Lastly, substrate adaptors SOCS2 and FBX6 of Cul2/5 have been reported to recruit AQP2. Constructs of FBX6 were not soluble. Similar problems were experienced with SOCS2, however when co-expressed with EloB/C, a ternary complex was successfully purified. This formed a stable complex with Cul5R1 and initial SPA analysis was performed. More particles will be collected to enable 3D reconstruction.
Due to no binding observed thus far, ubiquitin cascade was reconstituted to validate whether identified E3 ligases modify AQP2 in an isolated system. Although this difficult project had not been successfully finalized and the research period was finished, we will continuously challenge on this project because this is interesting and important for understanding homeostasis of human body through ubiquitination of AQP2.

Research Progress Status

令和4年度が最終年度であるため、記入しない。

Strategy for Future Research Activity

令和4年度が最終年度であるため、記入しない。

Report

(2 results)
  • 2022 Annual Research Report
  • 2021 Annual Research Report
  • Research Products

    (4 results)

All 2023 2022 Other

All Presentation (3 results) (of which Invited: 3 results) Remarks (1 results)

  • [Presentation] How to study protein structure2023

    • Author(s)
      Andrej Paluda
    • Organizer
      Science Dialogue (Tokyo Metropolitan High School of Science and Technology)
    • Related Report
      2022 Annual Research Report
    • Invited
  • [Presentation] How to study protein structure2022

    • Author(s)
      Andrej Paluda
    • Organizer
      Science Dialogue (Tochigi Prefectural Utsunomiya Girls’ High School)
    • Related Report
      2022 Annual Research Report
    • Invited
  • [Presentation] Science Dialogue2022

    • Author(s)
      Andrej Paluda
    • Organizer
      Nirasaki High School Science outreach program
    • Related Report
      2021 Annual Research Report
    • Invited
  • [Remarks] 東京医科歯科大学 高等研究院卓越研究部門 細胞構造生理学研究室 ホームページ

    • URL

      https://www.tmd.ac.jp/cesp/

    • Related Report
      2022 Annual Research Report 2021 Annual Research Report

URL: 

Published: 2021-07-29   Modified: 2024-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi